Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Microvisk appoints new board chairman

This article was originally published in Clinica

Executive Summary

Microvisk Technologies, a developer of rapid, point-of-care and home tests for blood coagulation disorders in patients taking warfarin, has appointed Ed Brennan as chairman of the board. Dr Brennan was most recently chairman (and an original investor) of HemoSense (bought by Massachusetts-based Inverness Medical Innovations in 2007), which developed and commercialised a product for monitoring warfarin therapy. Dr Brennan is a past president and CEO of San Diego-based CryoCor (products to treat cardiac rhythm disorders – bought by Boston Scientific in May 2008).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel